Search clinical trials for: docetaxel, doxorubicin, cyclophosphamide

Total 6530 results

University of California, San Francisco
National Cancer Institute (NCI)

Completed

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Breast Cancer | Fatigue | Neurotoxicity | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment | Long-term Effects Secondary to Cancer Therapy in Adults | Chemotherapeutic Agent Toxicity

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Cancer

United States
Seagen Inc.

Terminated

Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

Breast Cancer

United States
SCRI Development Innovations, LLC
Aventis Pharmaceuticals; Ortho Biotech, Inc.

Completed

Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer

Breast Cancer

United States
ARCAGY/ GINECO GROUP

Completed

Liposomal Doxorubicin and Docetaxel in Metastatic Breast Cancer

Metastatic Breast Cancer

France
NSABP Foundation Inc
National Cancer Institute (NCI)

Completed

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Breast Cancer

United States, Canada, Puerto Rico
Medical Research Council

Unknown

Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer

Ovarian Cancer

United Kingdom
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer

Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
Samyang Biopharmaceuticals Corporation

Recruiting

Compare the Efficacy and the Safety of Doxorubicin and Cyclophosphamide Followed by Taxotere Versus Doxorubicin and Cyclophosphamide Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer

Korea, Republic of
Seagen Inc.

Completed

Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer

Prostatic Neoplasms

United States
Fudan University

Recruiting

Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer (CLOVER)

Breast Cancer

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer

Breast Cancer

United States
Imunon

Unknown

Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer

Breast Cancer

United States
University of Wisconsin, Madison
Amgen

Completed

Dose Dense TC + Pegfilgrastim Support for Breast Cancer (ddTC)

Female Breast Cancer

United States
Sun Yat-sen University

Unknown

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Unrecognized Condition
Guangdong Provincial People's Hospital

Completed

TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer (neoCARH)

HER2-Positive Breast Cancer

China
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Aventis Pharmaceuticals

Completed

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

Breast Cancer

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Pyrotinib in Combination With Neoadjuvant Chemotherapy in HR+/HER2-, HER4 High Expression Breast Cancer Patients: A Phase II Trial

Breast Cancer | Hormone-receptor Positive Breast Cancer

China
Radboud University Medical Center
Sanofi; Amgen

Completed

Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer. (INTENS)

Breast Cancer

Netherlands
University of Yamanashi

Unknown

Study of Chemo-Immunotherapy in Head and Neck Cancer Patients

Head and Neck Cancer

Japan
Gruppo Italiano Mammella (GIM)

Completed

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Breast Cancer

Italy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.

Advanced Endometrial Cancer | Sarcoma of Uterus

China
Azaya Therapeutics, Inc.

Completed

Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies

Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Solid Tumor | Non-Small Cell Lung

United States
University of Regensburg
Essex Pharma Germany

Completed

Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma

Germany
Zivena

Unknown

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

NSCLC

United States
Xijing Hospital

Unknown

Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer

Breast Cancer

China
Ohio State University Comprehensive Cancer Center

Completed

Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer

Breast Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Breast Cancer

Breast Cancer

United States, Canada
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer

Breast Cancer

United States, South Africa
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Lung Cancer

France
Hebei Medical University Fourth Hospital

Unknown

A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer (TENDENCY)

Stage III Breast Cancer

China
Shanghai Jiao Tong University School of Medicine
Shanghai 10th People's Hospital; China-Japan Union Hospital, Jilin University; Ganzhou City People's Hospital

Recruiting

A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast (COC-IDCB)

Breast Cancer

China
Acrotech Biopharma Inc.
Axis Clinicals Limited

Unknown

PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

Hematologic Diseases
National University Hospital, Singapore

Unknown

Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient

Breast Cancer

Singapore
Merck Sharp & Dohme LLC
MDS Pharma Services

Completed

A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)

Breast Neoplasm
University of Sao Paulo General Hospital

Completed

Neurovascular Changes Induced by Chemotherapy

Breast Cancer | Chemotherapeutic Toxicity

Brazil
Yonsei University

Completed

Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

Breast Cancer

Korea, Republic of
National Cancer Centre, Singapore

Completed

Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses

Breast Cancer

Singapore
Western Regional Medical Center

Terminated

Fasting on Newly Diagnosed Breast Cancer (STEFNE)

HER2-positive Breast Cancer

United States
Lahey Clinic
Varian Medical Systems

Completed

Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant (SBRTvsTACE)

HCC | Hepatocellular Carcinoma

United States
Azienda Ospedaliero-Universitaria di Modena

Unknown

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

Breast Cancer

Italy
Korean Breast Cancer Study Group

Unknown

A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer (STORM)

Metastatic Breast Cancer | Recurrent Breast Cancer

Korea, Republic of
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer (ANZAC)

Breast Cancer

United Kingdom
University of Iowa
Aventis Pharmaceuticals

Terminated

Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Lahey Clinic
Varian Medical Systems; Merit Medical Systems, Inc.

Active, not recruiting

Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant (SBRTvsTACE)

HCC | Hepatocellular Carcinoma

United States, Canada
Instituto do Cancer do Estado de São Paulo
Fundação Faculdade de Medicina

Terminated

Feasibility Study of Metronomic Chemotherapy for Locally Advanced HER2-Negative Breast Cancer (TAME-01)

Locally Advanced HER2-negative Breast Cancer

Brazil
Children's Hospital Medical Center, Cincinnati

Completed

Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma

Neuroblastoma

Germany
Commissie Voor Klinisch Toegepast Onderzoek

Unknown

Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer

Lung Cancer

Netherlands
National Cancer Centre, Singapore

Terminated

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery

Breast Cancer

Singapore
NYU Langone Health

Completed

Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)

Breast Cancer

United States

3

Subscribe